Literature DB >> 8913701

Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.

W Schepp1, K Dehne, T Riedel, J Schmidtler, K Schaffer, M Classen.   

Abstract

We have previously shown that in highly enriched rat gastric parietal cells the intestinal peptide hormones oxyntomodulin and glucagon-like peptide-2 (GLP-2) compete for receptor-binding with glucagon-like peptide-1 (GLP-1), a potent cAMP-dependent stimulus of H+ production in vitro. It is, however, unknown whether oxyntomodulin and GLP-2 elicit a biological response by interacting with the GLP-1 receptor. Therefore, we used enriched rat parietal cells to investigate the effects of both hormones on the production of cAMP and H+ ([14C]aminopyrine accumulation). Both parameters were stimulated by oxyntomodulin in a concentration-dependent manner. EC50 values were 6.2.10(-8) and 2.5.10(-7) M oxyntomodulin for stimulation of H+ and cAMP production, respectively. The maximally effective concentrations for stimulation of [14C]aminopyrine accumulation and cAMP production were 1.10(-6) and 1.10(-5) M oxyntomodulin, respectively. At these concentrations oxyntomodulin was nearly as effective as 10(-4) M histamine and equally effective as 10(-8) M GLP-1 (7-36)NH2. In the enriched parietal cell preparation there was no immunocytochemical evidence of contaminating D cells. Accordingly, the responses to oxyntomodulin and GLP-1 (7-36)NH2 were not augmented by incubating the cells in the presence of a polyclonal anti-somatostatin antibody. [14C]Aminopyrine accumulation in response to oxyntomodulin was inhibited by the GLP-1 (7-36)NH2 receptor antagonist, exendin (9-39)NH2, but not by the H2-receptor antagonist, ranitidine. Oxyntomodulin and carbachol acted additively to stimulate [14C]aminopyrine accumulation. GLP-2 (10(-7) to 10(-5)M) was without effect on basal H+ and cAMP production; however, at 10(-5) M GLP-2 markedly inhibited oxyntomodulin-stimulated [14C]aminopyrine accumulation. It is concluded that, by interacting with parietal cell receptors for GLP-1 (7-36)NH2, oxyntomodulin, but not GLP-2, directly stimulates H+ production by activating the adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913701     DOI: 10.1159/000201367

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

Review 1.  Gastrointestinal hormones regulating appetite.

Authors:  Owais Chaudhri; Caroline Small; Steve Bloom
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 2.  Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.

Authors:  Charlotte X Dong; Patricia L Brubaker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

3.  Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.

Authors:  Yazhou Li; Kou-Jen Wu; Seong-Jin Yu; Ian A Tamargo; Yun Wang; Nigel H Greig
Journal:  Exp Neurol       Date:  2016-11-14       Impact factor: 5.330

Review 4.  Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.

Authors:  K Pabreja; M A Mohd; C Koole; D Wootten; S G B Furness
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 5.  Unraveling oxyntomodulin, GLP1's enigmatic brother.

Authors:  Alessandro Pocai
Journal:  J Endocrinol       Date:  2012-09-27       Impact factor: 4.286

6.  Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast.

Authors:  C Weston; D Poyner; V Patel; S Dowell; G Ladds
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

7.  Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2).

Authors:  Cathryn Weston; Jing Lu; Naichang Li; Kerry Barkan; Gareth O Richards; David J Roberts; Timothy M Skerry; David Poyner; Meenakshi Pardamwar; Christopher A Reynolds; Simon J Dowell; Gary B Willars; Graham Ladds
Journal:  J Biol Chem       Date:  2015-07-21       Impact factor: 5.157

Review 8.  Peptide hormones and lipopeptides: from self-assembly to therapeutic applications.

Authors:  J A Hutchinson; S Burholt; I W Hamley
Journal:  J Pept Sci       Date:  2017-01-27       Impact factor: 1.905

Review 9.  No Guts, No Loss: Toward the Ideal Treatment for Obesity in the Twenty-First Century.

Authors:  David C D Hope; Tricia M M Tan; Stephen R Bloom
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-15       Impact factor: 5.555

Review 10.  Action and therapeutic potential of oxyntomodulin.

Authors:  Alessandro Pocai
Journal:  Mol Metab       Date:  2013-12-14       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.